Jiangsu Trautec Medical Technology

A leading biotechnology company in Changzhou

Jiangsu Trautec Medical Technology Co., Ltd., founded in 2015, operates as a cosmetic lab and medical technology company in Changzhou, China. The company specializes in the development of recombinant collagen for both medical and cosmetic applications.

Advanced research and development facilities

Located in the Jintan Economic Development Zone, the company has invested over $17 million in research facilities dedicated to synthetic recombinant human collagen (SRHC) production. Their state-of-the-art laboratory complex houses equipment for biomaterial development and testing.

Product development and services

• Recombinant collagen-based biomaterials
• Innovative proteins development
• Nucleic acids production
• Medical and cosmetic applications research

Market position and recent growth

As a market leader in China’s SRHC industry, Trautec has achieved large-scale production capabilities. Their recent $27 million Series B investment in 2023 demonstrates market confidence in their technology and growth potential.

Strategic location in Jiangsu Province

The company’s location in Changzhou City, situated in Jiangsu Province, positions it within China’s biotechnology corridor. This placement provides access to research institutions and a skilled workforce in the region’s expanding biotech sector.

Manufacturing capabilities

The Jintan Economic Development Zone facility enables Trautec to maintain full control over their production chain, from research and development to final product manufacturing, ensuring quality standards across all processes.